• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染诱导的细胞因子风暴和免疫反应特征比较

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.

作者信息

Liu Tong, Feng Meng, Wen Zexin, He Yijie, Lin Wei, Zhang Min

机构信息

Department of Medicine, Xizang Minzu University, Xianyang, Shaanxi, People's Republic of China.

School of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.

出版信息

J Inflamm Res. 2021 Oct 23;14:5475-5487. doi: 10.2147/JIR.S329697. eCollection 2021.

DOI:10.2147/JIR.S329697
PMID:34720596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8550203/
Abstract

Cytokine storm (CS) is a significant cause of death in patients with severe coronavirus pneumonia. Excessive immune-inflammatory reaction, many inflammatory cell infiltration, and extreme increase of proinflammatory cytokines and chemokines lead to acute lung injury and acute respiratory distress syndrome (ARDS). This review compares the characters of cytokine storms and immune responses caused by three highly pathogenic and infectious coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome-coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and analyzes the possible mechanisms to guide clinical treatment in the future.

摘要

细胞因子风暴(CS)是重症冠状病毒肺炎患者死亡的重要原因。过度的免疫炎症反应、大量炎症细胞浸润以及促炎细胞因子和趋化因子的极度增加会导致急性肺损伤和急性呼吸窘迫综合征(ARDS)。本综述比较了三种高致病性传染性冠状病毒(HCoV),即严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的细胞因子风暴和免疫反应的特征,并分析了可能的机制,以指导未来的临床治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/7f6a953e82e7/JIR-14-5475-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/d1716fbc60ec/JIR-14-5475-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/7976da346d99/JIR-14-5475-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/7f6a953e82e7/JIR-14-5475-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/d1716fbc60ec/JIR-14-5475-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/7976da346d99/JIR-14-5475-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/100e/8550203/7f6a953e82e7/JIR-14-5475-g0003.jpg

相似文献

1
Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染诱导的细胞因子风暴和免疫反应特征比较
J Inflamm Res. 2021 Oct 23;14:5475-5487. doi: 10.2147/JIR.S329697. eCollection 2021.
2
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.致病性人类冠状病毒感染:细胞因子风暴和免疫病理学的成因及后果
Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2.
3
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
4
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.病毒感染期间的免疫系统反应:免疫调节剂、细胞因子风暴(CS)与COVID-19中的免疫疗法
Saudi Pharm J. 2021 Feb;29(2):173-187. doi: 10.1016/j.jsps.2020.12.018. Epub 2021 Jan 7.
5
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.在 COVID-19 中,单核细胞和巨噬细胞对局部组织炎症和细胞因子风暴的贡献:来自 SARS 和 MERS 的教训,以及潜在的治疗干预措施。
Life Sci. 2020 Sep 15;257:118102. doi: 10.1016/j.lfs.2020.118102. Epub 2020 Jul 18.
6
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.严重 COVID-19 中失调的干扰素反应和免疫过度激活:靶向 STATs 作为一种新的治疗策略。
Front Immunol. 2022 May 17;13:888897. doi: 10.3389/fimmu.2022.888897. eCollection 2022.
7
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
8
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.通过TRIF的Toll样受体3信号传导有助于对严重急性呼吸综合征冠状病毒感染产生保护性先天免疫反应。
mBio. 2015 May 26;6(3):e00638-15. doi: 10.1128/mBio.00638-15.
9
Immune Profiling of COVID-19 in Correlation with SARS and MERS.COVID-19 的免疫特征与 SARS 和 MERS 的相关性研究。
Viruses. 2022 Jan 17;14(1):164. doi: 10.3390/v14010164.
10
Role of cytokine storm in coronavirus infections: culprit or accomplice?细胞因子风暴在冠状病毒感染中的作用:元凶还是帮凶?
Front Biosci (Landmark Ed). 2022 Mar 17;27(3):102. doi: 10.31083/j.fbl2703102.

引用本文的文献

1
Structural proteins of human coronaviruses: what makes them different?人类冠状病毒的结构蛋白:它们有何不同之处?
Front Cell Infect Microbiol. 2024 Dec 6;14:1458383. doi: 10.3389/fcimb.2024.1458383. eCollection 2024.
2
A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data.一种用于整合局部-全局特征的深度学习药物筛选框架:针对有限数据的新尝试。
Heliyon. 2024 Jul 14;10(14):e34244. doi: 10.1016/j.heliyon.2024.e34244. eCollection 2024 Jul 30.
3
ANKRD22 aggravates sepsis-induced ARDS and promotes pulmonary M1 macrophage polarization.

本文引用的文献

1
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.SARS-CoV-2 的 ORF8 蛋白通过下调 MHC-Ι 实现免疫逃逸。
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). doi: 10.1073/pnas.2024202118.
2
Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity.中东呼吸综合征冠状病毒(MERS-CoV)、严重急性呼吸综合征冠状病毒(SARS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组中人类 Toll 样受体 7/8 刺激 RNA 基序的低组成意味着它们具有显著的逃避人类先天免疫的能力。
PeerJ. 2021 Feb 24;9:e11008. doi: 10.7717/peerj.11008. eCollection 2021.
3
锚蛋白重复结构域22(ANKRD22)加重脓毒症诱导的急性呼吸窘迫综合征并促进肺M1巨噬细胞极化。
J Transl Autoimmun. 2023 Dec 21;8:100228. doi: 10.1016/j.jtauto.2023.100228. eCollection 2024 Jun.
4
IL-10/IL-6 ratio from nasal & oral swab samples, acts as an inflammatory indicator for COVID-19 patients infected with the delta variant.来自鼻拭子和咽拭子样本的白细胞介素-10/白细胞介素-6比值,可作为感染德尔塔变异株的新冠患者的炎症指标。
Heliyon. 2023 Jun;9(6):e16985. doi: 10.1016/j.heliyon.2023.e16985. Epub 2023 Jun 3.
5
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses.致死性人类冠状病毒辅助蛋白在发病机制中的作用。
Front Cell Infect Microbiol. 2023 May 1;13:1166839. doi: 10.3389/fcimb.2023.1166839. eCollection 2023.
6
Chemokine Receptors-Structure-Based Virtual Screening Assisted by Machine Learning.基于机器学习辅助的趋化因子受体结构虚拟筛选
Pharmaceutics. 2023 Feb 3;15(2):516. doi: 10.3390/pharmaceutics15020516.
7
Association between expression of ZBP1, AIM2, and MDA5 genes and severity of COVID-19.ZBP1、AIM2和MDA5基因表达与新型冠状病毒肺炎严重程度的关联
EXCLI J. 2022 Sep 1;21:1171-1183. doi: 10.17179/excli2022-5141. eCollection 2022.
8
Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches.开发用于研究新治疗方法的严重急性呼吸综合征冠状病毒诱导的急性肺损伤体外模型。
Antioxidants (Basel). 2022 Sep 27;11(10):1910. doi: 10.3390/antiox11101910.
9
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.挺过风暴:SARS-CoV-2严重程度预测中的细胞因子生物标志物
Vaccines (Basel). 2022 Apr 14;10(4):614. doi: 10.3390/vaccines10040614.
10
Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities.冠状病毒和碳纳米管:寻求免疫关系以发现免疫治疗可能性。
Int J Nanomedicine. 2022 Feb 21;17:751-781. doi: 10.2147/IJN.S341890. eCollection 2022.
SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
SARS-CoV-2 感染诱导循环单核细胞中 M1/M2 表型混合,并改变树突状细胞和单核细胞亚群。
PLoS One. 2020 Dec 31;15(12):e0241097. doi: 10.1371/journal.pone.0241097. eCollection 2020.
4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的膜(M)蛋白通过靶向 RIG-I/MDA-5 信号通路抑制 I 型和 III 型干扰素的产生。
Signal Transduct Target Ther. 2020 Dec 28;5(1):299. doi: 10.1038/s41392-020-00438-7.
5
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
6
Evasion of Type I Interferon by SARS-CoV-2.SARS-CoV-2 对 I 型干扰素的逃避。
Cell Rep. 2020 Oct 6;33(1):108234. doi: 10.1016/j.celrep.2020.108234. Epub 2020 Sep 19.
7
Toll-like receptors and COVID-19: a two-faced story with an exciting ending.Toll样受体与新型冠状病毒肺炎:一个有着激动人心结局的双面故事。
Future Sci OA. 2020 Jul 30;6(8):FSO605. doi: 10.2144/fsoa-2020-0091.
8
SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核蛋白通过抑制信号转导和转录激活因子1(STAT1)和信号转导和转录激活因子2(STAT2)的磷酸化及核转位来拮抗I型干扰素信号传导。
Cell Discov. 2020 Sep 15;6:65. doi: 10.1038/s41421-020-00208-3. eCollection 2020.
9
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.SARS-CoV-2 ORF3b 是一种有效的干扰素拮抗剂,其活性可被一种自然发生的延长变异体增强。
Cell Rep. 2020 Sep 22;32(12):108185. doi: 10.1016/j.celrep.2020.108185. Epub 2020 Sep 4.
10
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.